Inaktiver Wert

Genzyme Corporation Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	28.06.11
Genzyme : succès de l'OPE de Sanofi-aventis.	04.04.11
GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	07.03.11
Genzyme : Sanofi-aventis modifie son offre.	07.03.11
GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	01.03.11

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31 %	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+0,56 %	95,28 Mrd.
ARGENX SE	+1,69 %	22,15 Mrd.
BIONTECH SE	-17,37 %	21,02 Mrd.
GENMAB A/S	-9,30 %	18,15 Mrd.
WUXI APPTEC CO., LTD.	-41,01 %	16,73 Mrd.
BEIGENE, LTD.	-14,85 %	16,05 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+3,21 %	13,68 Mrd.
SAREPTA THERAPEUTICS, INC.	+33,54 %	12,17 Mrd.